AT95243T
Anti-lymphotoxin antibody, its production and use
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
65 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 61650284 | United States of America | A | |
| 61650384 | United States of America | A | |
| 73231285 | United States of America | A |
Members65
| Document | Office | Kind | |
|---|---|---|---|
| DK241385D0 | Denmark | D0 | |
| PT80573A | Portugal | A | |
| IL75318D0 | Israel | D0 | |
| GR851317B | Greece | B | |
| IE851321L | Ireland | L | |
| IE930589L | Ireland | L | |
| DK241385A | Denmark | A | |
| FI852143L | Finland | L | |
| NO852173L | Norway | L | |
| AU4320385A | Australia | A | |
| EP0164965A2 | European Patent Office (EPO) | A2 | |
| HUT37814A | Hungary | A | |
| PL253739A1 | Poland | A1 | |
| JPS6156197A | Japan | A | |
| ZA854135B | South Africa | B | |
| PT80573B | Portugal | B | |
| EP0164965A3 | European Patent Office (EPO) | A3 | |
| ES8802182A1 | Spain | A1 | |
| YU91985A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| RO93651A | Romania | A | |
| RO93651B | Romania | B | |
| AU599303B2 | Australia | B2 | |
| US4959457A | United States of America | A | |
| RO100383B1 | Romania | B1 | |
| NZ212207A | New Zealand | A | |
| NZ226980A | New Zealand | A | |
| RO100383A2 | Romania | A2 | |
| HU204085B | Hungary | B | |
| PL155410B1 | Poland | B1 | |
| EP0509553A1 | European Patent Office (EPO) | A1 | |
| IL104297D0 | Israel | D0 | |
| EP0164965B1 | European Patent Office (EPO) | B1 | |
| AT95243TThis record | Austria | T | |
| DE3587597D1 | Germany | D1 | |
| AR245219A1 | Argentina | A1 | |
| BG60256B1 | Bulgaria | B1 | |
| BG60256B2 | Bulgaria | B2 | |
| DE3587597T2 | Germany | T2 | |
| IL75318A | Israel | A | |
| FI93025B | Finland | B | |
| FI93025C | Finland | C | |
| IE63487B1 | Ireland | B1 | |
| DK56995A | Denmark | A | |
| JPH07250692A | Japan | A | |
| JPH07291995A | Japan | A | |
| YU47735B | Yugoslavia, later Serbia and Montenegro (until 2006) | B | |
| NO179075B | Norway | B | |
| NO179075C | Norway | C | |
| JP2521703B2 | Japan | B2 | |
| SK278333B6 | Slovakia | B6 | |
| SK393085A3 | Slovakia | A3 | |
| DK171531B1 | Denmark | B1 | |
| CZ393085A3 | Czechia | A3 | |
| US5683688A | United States of America | A | |
| CZ283148B6 | Czechia | B6 | |
| DK172382B1 | Denmark | B1 | |
| IL104297A | Israel | A | |
| JP2804237B2 | Japan | B2 | |
| US5824509A | United States of America | A | |
| CA1340641C | Canada | C | |
| EP0509553B1 | European Patent Office (EPO) | B1 | |
| AT195323T | Austria | T | |
| DE3588225D1 | Germany | D1 | |
| US6177543B1 | United States of America | B1 | |
| DE3588225T2 | Germany | T2 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Cancelled due to lapse of timeLapsedEELA | EELA | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 85303818
Titles2
- German
- LYMPHOTOXIN, DAFUER KODIERENDE NUKLEINSAEURE, DIE NUKLEINSAEURE ENTHALTENDEN VEKTOREN UND DAMIT TRANSFORMIERTE ZELLEN, VERFAHREN ZUM ERHALTEN VON LYMPHOTOXIN UND LYMPHOTOXIN NEUTRALISIERENDER ANTIKOERPER.
- English
- LYMPHOTOXINE, DAFUER-CODING NUCLEIC ACID, NUCLEIC ACID-CONTAINING VECTORS AND CELLS TRANSFORMED THEREWITH, PROCESS FOR OBTAINING LYMPHOTOXIN AND LYMPHOTOXINE NEUTRALIZING ANTICOERPER.
Classification
- CPC, 5
- C07K16/242
- A61K38/00
- A61P35/00
- C07K14/5255
- C07K16/241
- IPC, 30
- C12N15 09
- A61K35 74
- A61K38 00
- A61K38 16
- A61K39 395
- A61P35 00
- C07K1 00
- C07K1 22
- C07K14 00
- C07K14 005
- C07K14 195
- C07K14 435
- C07K14 52
- C07K14 525
- C07K16 00
- C07K16 18
- C07K16 24
- C07K17 00
- C07K19 00
- C12N1 20
- C12N1 21
- C12N15 00
- C12N15 02
- C12P21 00
- C12P21 02
- C12P21 08
- C12R1 19
- C12R1 91
- G01N33 50
- G01N33 53